Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.
about
Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte ModelCell-intrinsic innate immune control of West Nile virus infection.TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidateSubcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells.Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
P2860
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@ast
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@en
type
label
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@ast
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@en
prefLabel
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@ast
Intrinsic adjuvanting of a nov ...... interferon receptor signaling.
@en
P2093
P2860
P1433
P1476
Intrinsic adjuvanting of a nov ...... interferon receptor signaling
@en
P2093
Evandro R Winkelmann
Frank Scholle
Jingya Xia
Michelle H Nelson
Mindy Miller-Kittrell
Nigel Bourne
Peter W Mason
Tomohiro Ishikawa
P2860
P304
P356
10.1016/J.VACCINE.2011.12.103
P407
P577
2012-01-05T00:00:00Z